3 completed, 1 terminated. 2 Phase 1, 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Early Phase 1 | 1 | Terminated 1 |
| Not applicable | 1 | Completed 1 |
Follow Cefpodoxime Proxetil: new trials by email Literature Review of Cefpodoxime Proxetil trials Research Report on Cefpodoxime Proxetil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK, the Measure of How the Human Body Processes a Substance) of ETX0282 When Administered Orally to Healthy Participants ETX0282, Cefpodoxime proxetil, Placebo - Healthy Volunteers | Phase 1 | Completed | Entasis Therapeutics | 99 | 2018-03-16 | 2020-01-14 |
| Healthy Patients & Effect of Antibiotics Levofloxacin, Azithromycin, Cefpodoxime - Microbiota, Anti-bacterial Agents | Not applicable | Completed | Washington University School of Medicine | 20 | 2017-01-01 | 2022-11-10 |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
| A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors Bevacizumab, Temozolomide, Vincristine - Solid Tumor | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 13 | 2008-10-01 | 2021-02-10 |
Enterobacteriaceae Infections (1) · Osteomyelitis (1)
Children's Hospital Medical Center, Cincinnati (1) · Entasis Therapeutics (1) · Julio Ramirez (1) · Washington University School of Medicine (1)
United States (3) · Australia (1)
Brian Turpin, D.O. (1) · David Seligson, MD (1) · Jennie H. Kwon, DO, MSCI (1) · Julio Ramirez, MD (1)
PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 4902833, PMID 8948280